Arese Pharma

What Arese Pharma does

Arese Pharma is a privately-held Brazilian pharmaceutical manufacturer founded in 1990 and headquartered in Valinhos, São Paulo, operating a single integrated facility with capacity of 175 million units per year across injectables, solids, liquids, and semi-solids. The company produces both prescription medicines and dietary supplements under pharmaceutical-grade standards, with the distinctive technical feature of applying WFI (Water for Injection) purity to its entire product line — including non-sterile supplements — and holding the ANVISA CBPF certification. Its product portfolio spans pediatric nutrition (Zirvit Kids, market leader in pediatric prescription), women's health and prenatal care, bone and joint health (Ossone, Flexone), immunology (Becan with Beta-glucan, Enax with Echinacea Purpurea, Becan LF with Lactoferrin), cognitive support (Deaten with Phosphatidylserine), injectables (Nevrix IM, the sole injectable B1/B6/B12 combination in Brazil), and a long tail of antifungals, antibiotics, contraceptives, and anxiolytics.

The business model is a prescription-driven B2B2C sales motion: Arese deploys a field force that conducts approximately 540,000 medical visits per year to pediatricians, gynecologists, orthopedists, GPs, and geriatricians, who then prescribe Arese products dispensed through Brazil's pharmacy network of more than 70,000 points of sale across all major chains (Droga Raia, Drogaria São Paulo, Pague Menos, Drogasil, Pacheco, among others). Revenue is generated through one-time product sales with no disclosed subscription, licensing, or direct-to-consumer channels. The company reports self-funded organic growth (no external funding rounds disclosed), expanding capacity 2.5x in 2023 and launching 12 new SKUs in 2025 plus three more in 2026, supported by R&D partnerships with UFRGS, USP, UNESP, UNICAMP, and the Brazilian Association of Nutrology (ABRAN). The stated corporate trajectory is to double in size every three years, with the company reporting delivery of over 50 million cumulative treatments to the Brazilian population.

Name

Arese Pharma

Legal name

Arese Pharma

Website

https://arese.com.br

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

101–250 employees

Short description

Arese Pharma is a privately-held Brazilian pharmaceutical manufacturer founded in 1990, producing prescription medicines and dietary supplements at pharmaceutical-grade quality and distributing them through over 70,000 Brazilian pharmacies via a 540,000-visit-per-year field sales force targeting prescribers in pediatrics, gynecology, orthopedics, general practice, and geriatrics.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Immunology & Inflammation Pharmaceuticals (HLAIAAAD)

Keywords

• Pharmaceutical manufacturing
• Nutraceutical supplements
• Injectable vitamins
• Women's health supplements
• Pediatric vitamins

Headquarters

HQ city

Valinhos

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical and supplement product sales: Arese Pharma generates revenue through the manufacture and sale of prescription medicines, over-the-counter supplements, and nutraceutical products. Products are sold through major Brazilian pharmacy chains and independent drugstores, with distribution across more than 70,000 points of sale nationwide.

Go-to-market motion1 record

Distribution channels10 records

Marketing channels7 records

Core offering

Arese Pharma manufactures and sells prescription medicines, over-the-counter supplements, and nutraceutical products through Brazilian retail pharmacies. The company's product portfolio includes B-complex medications, pediatric vitamins, women's health supplements, bone and joint health products, immunostimulants, cognitive support supplements, digestive aids, and various other pharmaceuticals across multiple delivery forms including injectables, tablets, capsules, syrups, drops, and creams.

Product overview

Arese Pharma is a Brazilian pharmaceutical company with over 30 years of experience, offering a diverse portfolio of supplements and medicines. The product portfolio includes B-complex medications (Nevrix, Nevrix Flash, Nevrix IM, Dexador), bone health supplements (Ossone, Ossone Max), pediatric vitamins (Zirvit Kids, Zirvit Kids Max), women's health products (Colpist MT, Zirvit Pré, Zirvit Vita, Zirvit Vita Max), immunostimulants (Becan, Becan LF, Enax, Lacfer ADZ), cognitive support supplements (Deaten), digestive aids (Intoliv, Precol Intoliv, Folifer), and various other medications across categories including antibiotics, antifungals, contraceptives, anti-inflammatory, and anxiolytics. The company operates a manufacturing facility in Valinhos, São Paulo with capacity of 175 million units per year, producing solids (tablets, capsules, powders), liquids (syrups, drops, suspensions), semi-solids (creams, ointments), and injectables. Products are distributed through over 70,000 pharmacies across Brazil.

Differentiator

Problem solved

Functional benefit

Products and services

• Becan Beta-glucan (from Saccharomyces cerevisiae yeast), vitamins C and D, and zinc-based immunostimulant dietary supplement for immune system support.
• Becan LF (Cápsulas and Gotas) Beta-glucan combined with Lactoferrin plus vitamins C, D, and zinc; available in capsule form and pediatric oral drops for enhanced immunity support.
• Nevrix IM Injectable B-complex medication containing vitamins B1, B6, and B12 for neurological support; unique injectable offering on the Brazilian market.
• Nevrix Oral B-complex medication with cyanocobalamin, pyridoxine, and thiamine for neurological support.
• Dexador Dexamethasone with cyanocobalamin, pyridoxine, and thiamine; anti-inflammatory medication for neurological support.
• Ossone Bone health supplement with calcium, K2-7, D3, magnesium, and manganese for bone density support.
• Ossone Max Advanced bone health supplement combining calcium bisglycinate and citrate-malate, vitamin D, vitamin K2-7, boron, manganese, magnesium, MSM, type II collagen, and hyaluronic acid.
• Zirvit Kids Pediatric vitamin, mineral, and omega 3 supplement in suspension for children; leader in pediatric prescription in Brazil.
• Zirvit Kids Max Pediatric vitamin and mineral supplement rich in vitamin D, iron, and plant-based Omega 3 for children.
• Zirvit Multi Max Vitamin and mineral supplement with amino acids and caffeine for adult nutritional support.
• Zirvit Pr\u00e9 Prenatal supplement with choline, L-methylfolate, and vitamin B12 for pregnancy-related nutritional support.
• Zirvit Vita Max Vitamin supplement for pregnant women containing 24 nutrients, chelated minerals, calcium, choline, and DHA.
• Deaten Cognitive support supplement containing microalgae oil (Schizochytrium sp.) with DHA and soy lecithin with high phosphatidylserine content.
• Enax Phytomedicine containing Echinacea purpurea L. for immune system support; first pharmaceutical formulation with this molecule in Brazil.
• Flexone Joint health supplement containing hyaluronic acid, type II collagen, glucosamine, and curcumin.
• Folifer (Comprimidos and Gotas) Ferrous bisglycinate chelate mineral supplement available in tablets and oral suspension drops for iron supplementation.
• Colpist MT Gynecological anti-infective medication with benzoilmetronidazol, nistatina, and cloreto de benzalcônio for women's health.
• Becan LF Caps Capsule form of Becan LF combining Beta-glucan with Lactoferrin for immunity support.
• Intoliv Enzymatic preparation based on alpha-galactose from Aspergillus niger, lactase from Aspergillus oryzae, and protease from Aspergillus niger for digestive intolerance support.
• Precol Digestive supplement containing Beta-galactosidase and Alpha-galactosidase enzymes for digestive support.
• Ossone Max and Additional 2025 Innovations (Softol, Rinilav, Proidrat, Otodrat, Zirvit BHO, Lacfer ADZ, Cistop) Multiple standalone products launched in 2025: Softol (simeticona antiflatulent medication), Rinilav (sodium chloride nasal solution), Proidrat (hydration supplement with electrolytes, zinc, and Lactobacillus Rhamnosus GG), Otodrat (hydrating ear care solution with Bisabolol and Urea), Zirvit BHO (vitamin and mineral oral suspension), Lacfer ADZ (Lactoferrin with vitamins A, D, and zinc supplement), and Cistop (chewable urinary tract supplement).
• Posvir and Nevrix Flash Posvir (food supplement with bioactive substances, vitamins, and minerals) and Nevrix Flash (B-complex with active forms of substances for neurological support).

Quantifiable outcome

• Over 50 million treatments provided to the Brazilian population over the past years
• +5 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core.

• UFRGS (Universidade Federal do Rio Grande do Sul)coreStrategic or Co-development Partner · 1 January 1999University research partnership initiated in 1999 for collaborative R&D projects in nutraceuticals and pharmaceuticals. UFRGS is one of Brazil's leading public universities in health sciences.
• USP (Universidade de São Paulo)coreStrategic or Co-development Partner · 1 January 1999University research partnership initiated in 1999 for collaborative R&D projects in nutraceuticals and pharmaceuticals. USP is the largest public university in Brazil.
• UNESP (Universidade Estadual Paulista)coreStrategic or Co-development Partner · 1 January 1999University research partnership initiated in 1999 for collaborative R&D projects in nutraceuticals and pharmaceuticals.
• UNICAMP (Universidade Estadual de Campinas)coreStrategic or Co-development Partner · 1 January 1999University research partnership initiated in 1999 for collaborative R&D projects in nutraceuticals and pharmaceuticals. UNICAMP is one of Brazil's most prestigious research universities.
• ABRAN (Associação Brasileira de Nutrologia)coreStrategic or Co-development PartnerStrategic partnership with the Brazilian Association of Nutrology. Arese is a partner in technical-scientific events organized by ABRAN. The Director responsible for the Department of Nutraceuticals and Phytotherapeutics at ABRAN endorses Arese as a laboratory that invests in technology and science for the development of nutraceutical and phytotherapeutic supplements and medicines.

Scale indicators9 records

Recent moves9 records

Expansion highlights4 records

Direct peers

• Eurofarma Laboratórios: Brazilian branded pharma manufacturer with a multi-therapeutic portfolio (primary care, specialty, hospital) and growing OTC/supplement lines. Comparable to Arese on branded pharmaceutical manufacturing and broad prescriber coverage, but with materially greater international and R&D scale.
• EMS Pharma: Largest pharmaceutical company in Brazil by volume, with a broad branded-generic portfolio across primary care, women's health and supplements. Highly comparable to Arese's branded pharma + supplement mix and physician-channel GTM, though several times Arese's scale.
• Farmoquímica: Brazilian pharmaceutical manufacturer focused on women's health, pediatrics and specialty prescriptions — directly comparable to Arese's physician-led franchise strategy and category mix.
• Aché Laboratórios: Brazilian mid-to-large pharmaceutical company with branded primary care, women's health and consumer health adjacencies and a strong physician sales force. Closely matches Arese's prescription-led GTM and therapeutic mix.
• Cifarma Científica Farmacêutica: Mid-sized Brazilian generic and branded pharma manufacturer with distribution through major pharmacy chains. Comparable in scale and product breadth to Arese on the pharmaceutical manufacturing side.
• Biolab Farmacêutica: Brazilian branded pharma company with strong franchises in women's health, pediatrics and specialty categories — overlapping directly with Arese's core focus areas. Similar mid-cap size and physician-led commercial model.
• Libbs Farmacêutica: Brazilian specialty and women's health-focused pharmaceutical company with branded Rx and OTC products. Comparable to Arese on women's health positioning and prescriber-channel presence.
• Marjan Farmacêutica: Brazilian pharma manufacturer with branded Rx and OTC products distributed through Brazilian retail pharmacies. Comparable distribution and channel dynamics to Arese, with a similar mid-cap profile.

Emerging players

• Probiótica Laboratórios: Brazilian nutraceutical and sports-nutrition manufacturer with a growing mass-market supplement portfolio sold through pharmacy and retail channels. Comparable to Arese on the supplement/injectable quality differentiation narrative, though Arese's products are more prescription-driven.

Broad incumbents

• Hyper S/A (Hyper Pharma): Largest Brazilian pharma by revenue, with branded Rx, generics, OTC and consumer health brands distributed nationwide via retail pharmacy chains. Comparable distribution footprint and channel dynamics to Arese; broader portfolio and OTC brand presence.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@AresePharmaOficial
• Facebookfacebook.com/aresepharma
• LinkedInlinkedin.com/company/arese-pharma
• Instagraminstagram.com/aresepharma
• TikToktiktok.com/@aresepharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arese Pharma